Riskpilot← Back to searchSign inGet full accessMedisize Oy
OYActiveY-tunnus 2046714-2Ensolantie 10Manufacture of other plastic products · NACE 2226Est. 20064 employeeswww.medisize.com
Revenue 2024
EUR 245,1M
+24% vs 2023
EBITDA margin
28.4%
+45% vs 2023
Equity ratio
63.0%
Financial strength
Net profit 2024
EUR 51,7M
+53% vs 2023
| Revenue | EUR 245,1M | +24% |
| EBITDA | EUR 69,7M | +45% |
| Net profit | EUR 51,7M | +53% |
| Total assets | EUR 283,8M | +18% |
| Equity | EUR 178,9M | +45% |
| Employees | 4 | — |
Legal name
Medisize Oy
Y-tunnus number
2046714-2
Legal form
Osakeyhtiö
NACE code
2226 · Manufacture of other plastic products
Founded
3. heinäkuuta 2006
Share capital
EUR 38 608 000
Employees
4 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja yhdessä
Company purpose
Yhtiön toimialana on suunnitella ja valmistaa ja myydä metalli- ja muovialan tuotteita sekä harjoittaa neuvottelevaa insinööritoimintaa. Yhtiö harjoittaa myös vientiä ja tuontia sekä agentuuriliikettä muovi- ja metallialan tuotteilla. Yhtiö voi omistaa ja hallita kiinteistöjä sekä osakkeita ja muita arvopapereita.
Address
Ensolantie 10
Phone
+3580102892400
Email
etunimi.sukunimi@phillips-medisize.com
Website
www.medisize.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 106 437 | 119 841 | 131 479 | 197 395 | 245 120 |
| Staff expenses | −29 655 | −34 828 | −33 216 | −57 134 | −63 277 |
| EBITDA | 27 895 | 30 753 | 29 459 | 47 961 | 69 713 |
| Depreciation & amort. | −4 776 | −4 697 | −3 212 | −4 356 | −6 561 |
| EBIT | 23 119 | 26 056 | 26 248 | 43 605 | 63 152 |
| Net financials | −4 406 | −7 157 | −9 451 | −496 | −574 |
| Profit before tax | 18 154 | 19 025 | 15 557 | 43 109 | 62 578 |
| Tax | 4 006 | 3 449 | 3 420 | 9 204 | 10 843 |
| Net profit | 14 148 | 15 576 | 12 138 | 33 905 | 51 735 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 139 213 | 157 043 | 141 374 | 239 546 | 283 784 |
| Equity | 48 297 | 63 772 | 76 901 | 123 017 | 178 882 |
| Long-term debt | 68 652 | 649 | 33 366 | 31 443 | 33 440 |
| Short-term debt | 22 264 | 92 622 | 31 107 | 85 086 | 71 461 |
| Total debt | 90 917 | 93 271 | 64 473 | 116 529 | 104 902 |
EBITDA margin
28.4%
This company
15.8%
Market median
+80% vs market
20202024
Equity ratio
63.0%
This company
38.2%
Market median
+65% vs market
20202024
Return on equity
28.9%
This company
18.4%
Market median
+57% vs market
20202024
Net profit margin
21.1%
This company
8.1%
Market median
+160% vs market
20202024
Asset turnover
0.86×
This company
1.12×
Market median
+23% vs market
20202024
Debt / equity
0.59×
This company
0.62×
Market median
+5% vs market
20202024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
DR Chief Executive Officer | Chief Executive Officer | 2024 |
EB Confidential Clerk | Confidential Clerk | 2023 |
KM Person with significant control | Person with significant control | 2020 |
JP Confidential Clerk | Confidential Clerk | 2023 |
| Former (8) | ||
CD Confidential Clerk | Confidential Clerk | 2017 – 2020 |
IK | Audit | 2019 – 2023 |
Wv Chief Executive Officer | Chief Executive Officer | 2008 – 2020 |
TA Chief Executive Officer | Chief Executive Officer | 2020 – 2024 |
IM Confidential Clerk | Confidential Clerk | 2022 – 2024 |
JP Confidential Clerk | Confidential Clerk | 2024 – 2025 |
MK Confidential Clerk | Confidential Clerk | 2017 – 2022 |
JT Audit | Audit | 2018 – 2019 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2023 | |
| Former (4) | ||
| Chairperson | 2017 – 2020 | |
| Board of Directors | 2020 – 2023 | |
| Board of Directors | 2020 – 2023 | |
| Board of Directors | 2017 – 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Medisize Oy (this company)
Medisize Schweiz AG, SveitsiMedisize Medical Business Beheer BV, Alankomaat -konserniMedisize Medical Holdings S.a.r.l., LuxemburgPhillips-Medisize Poland Sp. z.o.o., PuolaBoard members of Medisize Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| David Russell Thoreson | Chief Executive Officer | 0 companies |
| Christof Dirk Plätzer | Confidential Clerk | 0 companies |
| Eamon Brian Giles | Confidential Clerk | 0 companies |
| Ilkka Kristian Kujala | Audit | 0 companies |
| Willem van den Bruinhorst | Chief Executive Officer | 0 companies |
| Tomasz Artur Walesa | Chief Executive Officer | 0 companies |
| Ilari Martti Varhimo | Confidential Clerk | 0 companies |
| Juri Petteri Jukola | Confidential Clerk | 0 companies |
| Katherine Mary Dornan | Person with significant control | 0 companies |
| Minna Kaarina Havula | Confidential Clerk | 0 companies |
| Juha Tapani Nenonen | Audit | 0 companies |
| Jari Pekka Mononen | Confidential Clerk | 0 companies |
| Matthew Jon Jennings | Chairperson | 0 companies |
| David William Cole | Board of Directors | 0 companies |
| Michal Andrzej Klimek | Board of Directors | 0 companies |
| Jari Perttu Huovinen | Board of Directors | 0 companies |
| Norman Charles Roegner III | Board of Directors | 0 companies |